RAC 2.37% $1.65 race oncology ltd

Cardioprotection thread, page-236

  1. 365 Posts.
    lightbulb Created with Sketch. 815
    I asked @Davisite a similar question a while ago. In regards to drugs likely to be encountered in the upcoming P1 trial:

    https://hotcopper.com.au/data/attachments/5996/5996771-7e95c9046a62f6fa49d43c427440c1b7.jpg

    The actual post is here: https://hotcopper.com.au/posts/71178208/single

    I assume in relation to synergies with other classes of drugs, they will probably need to wait for other trials, and possibly additional pre-clinicals firstly.
    Last edited by KingBuzzo: 29/02/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.